1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine

C27H31N5O4 — CID 51699860

IUPAC1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine
SMILESCOc1cc(CN(C[C@H]2CCCO2)c2ncnc3c2cnn3-c2ccccc2C)cc(OC)c1OC
InChIInChI=1S/C27H31N5O4/c1-18-8-5-6-10-22(18)32-27-21(14-30-32)26(28-17-29-27)31(16-20-9-7-11-36-20)15-19-12-23(33-2)25(35-4)24(13-19)34-3/h5-6,8,10,12-14,17,20H,7,9,11,15-16H2,1-4H3/t20-/m1/s1
InChIKeyVJBNSNHQGAYNOX-HXUWFJFHSA-N
MW489.58 g/mol
LogP4.34
Rot. Bonds9

About 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine

1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine (PubChem CID 51699860) has the molecular formula C27H31N5O4 and a molecular weight of 489.58 g/mol. Its IUPAC name is 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine.

Molecular Properties

Compound Name1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine
PubChem CID51699860
Molecular FormulaC27H31N5O4
Molecular Weight489.58 g/mol
Exact Mass489.24
IUPAC Name1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine
SMILESCOc1cc(CN(C[C@H]2CCCO2)c2ncnc3c2cnn3-c2ccccc2C)cc(OC)c1OC
InChIInChI=1S/C27H31N5O4/c1-18-8-5-6-10-22(18)32-27-21(14-30-32)26(28-17-29-27)31(16-20-9-7-11-36-20)15-19-12-23(33-2)25(35-4)24(13-19)34-3/h5-6,8,10,12-14,17,20H,7,9,11,15-16H2,1-4H3/t20-/m1/s1
InChIKeyVJBNSNHQGAYNOX-HXUWFJFHSA-N
XLogP4.34
TPSA83.76 Ų
H-Bond Donors
H-Bond Acceptors9
Rotatable Bonds9
Heavy Atoms36
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500489.58
LogP ≤ 54.34
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 109

Analyze 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine?
The IUPAC name of 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine (CID 51699860) is 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine.
What is the SMILES notation for 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine?
The canonical SMILES for 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine is COc1cc(CN(C[C@H]2CCCO2)c2ncnc3c2cnn3-c2ccccc2C)cc(OC)c1OC.
What is the InChIKey of 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine?
The InChIKey is VJBNSNHQGAYNOX-HXUWFJFHSA-N. The full InChI is InChI=1S/C27H31N5O4/c1-18-8-5-6-10-22(18)32-27-21(14-30-32)26(28-17-29-27)31(16-20-9-7-11-36-20)15-19-12-23(33-2)25(35-4)24(13-19)34-3/h5-6,8,10,12-14,17,20H,7,9,11,15-16H2,1-4H3/t20-/m1/s1.
What are the key properties of 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine?
1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine has a molecular weight of 489.58 g/mol, XLogP of 4.34, 9 rotatable bonds, 0 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(2-methylphenyl)-N-[[(2R)-oxolan-2-yl]methyl]-N-[(3,4,5-trimethoxyphenyl)methyl]pyrazolo[5,4-d]pyrimidin-4-amine is sourced from PubChem (CID 51699860), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).